Progress in clinical immunotherapy for tumors

References

• Coggin JH Jr, Anderson NG: Cancer, differentiation and embryonic antigens: Some central problems. Adv Cancer Res 19:105–165, 1974
   PubMedGoogle Scholar
• Littman B, Zbar B, Rapp HJ: Effects of Mycobacterium bovis (BCG) on tumor cell growth in muscle. Proc AACR 13:96, 1972
   Google Scholar
• Sinkovics JG, Ahearn MJ, Shirato E, et al: Viral leukemogenesis in immunologically and hematologically altered mice. J Reticuloendothel Soc 8:474–492, 1970
   PubMedGoogle Scholar
• Hirano M, Sinkovics JG, Shullenberger CC, et al: Murine lymphoma: Augmented growth in mice with pertussis vaccine-induced lymphocytosis. Science 158:1061–1064, 1967
   PubMed Web of Science ®Google Scholar
• Rios A, Simmons RL: Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine. Surgery 75:503–507, 1974
   PubMed Web of Science ®Google Scholar
• Froese G, Berczi I, Sehon AH: Neuraminidase-induced enhancement of tumor growth in mice. J Natl Cancer Inst 52: 1905–1908, 1974
   PubMedGoogle Scholar
• Gazdar AF, Weinstein AJ, Sims HL, et al: Enhancement and suppression of murine sarcoma virus induced tumors by polyriboinosinc-polyribocytidylic acid. Proc Soc Exp Biol Med 139:279–285, 1972
   PubMed Web of Science ®Google Scholar
• Sinkovics JG: Immunology of tumors in experimental animals. In Harris JE, Sinkovics JG: The Immunology of Malignant Disease. Ed 2. St. Louis, The CV Mosby Co, 1976 (in press)
   Google Scholar
• Bortin MM: Graft versus leukemia. In Bach FH, Good RA (Editors): Clinical Immunobiology. New York, Academic Press, Inc, 1974, pp 287–306
   Google Scholar
• Hirsch MS, Black PH: Activation of mammalian leukemia viruses. Adv Virus Res 12:265–313, 1974
   Google Scholar
• Klein E, Holtermann OA, Case RW, et al: Responses of neoplasms to local immunotherapy. Am J Clin Pathol 62:281–289, 1974
   PubMed Web of Science ®Google Scholar
• Hibbs JB Jr: Macrophage nonimmunologic recognition: Target cell factors related to contact inhibition. Science 180:868–870, 1973
   PubMed Web of Science ®Google Scholar
• Minden P, McClatchy JK, Wainberg M, et al: Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J Nad Caner Inst 53:1325–1331, 1974
   PubMed Web of Science ®Google Scholar
• Young RC, Corder MP, Berard CW, et al: Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. Arch Intern Med 131:446–454, 1973
   PubMedGoogle Scholar
• Harris JE, Bagai RC, Stewart TH: Serial monitoring of immune reactivity in cancer patients receiving chemotherapy as a mean of predicting antitumor response. In Daguillard P (Editor): Proceedings of Seventh Leukocyte Culture Conference. New York, Academic Press, Inc, 1973, pp 443–457
   Google Scholar
• Golub SH, O'Connell TX, Morton DL: Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res 34:1833–1837, 1974
   PubMed Web of Science ®Google Scholar
• Tarpley JL, Potvin C, Chretien PB: Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy. Cancer 35:638–644, 1975
   PubMed Web of Science ®Google Scholar
• Mott MG: Chemotherapeutic suppression of immune enhancement: A primary determinant of successful cancer therapy. Lancet 1:1092–1094, 1973
   PubMed Web of Science ®Google Scholar
• Sinkovics JG, Williams DE, Kay HD, et al: Clinical settings favorable for immunotherapy of sarcomas. In: Interaction of Radiation and Host Immune Defense Mechanism in Malignancy. Brookhaven National Laboratory, U.S. Atomic Energy Commission, 1974, pp 331–339
   Google Scholar
• Herberman RB: Immune responses to virus induced experimental leukemia and to human leukemia. In Beers RF Jr, Tilghman RC, Bassett EG (Editors): The Role of Immunological Factors in Viral and Oncogenic Processes. Johns Hopkins Med J 3:3–14, 1974
   Google Scholar
• Sinkovics JG, Williams DE, Campos LT, et al: Intensification of immune reactions of patients to cultured sarcoma cells: Attempts at monitored immunotherapy. Seminars in Oncology 1:351–365, 1974
   PubMedGoogle Scholar
• Wood WC, Morton DL: Host immune response to a common cell-surface antigen in human sarcomas. N Engl J Med 284:569–572, 1971
   PubMed Web of Science ®Google Scholar
• Lewis MG: Mechanisms of humoral tumor immunity in malignant melanoma. In Scholefield PG (Editor): Proceedings of the Tenth Canadian Cancer Research Conference. National Cancer Institute of Canada, University Toronto Press, 1973, pp 113–129
   Google Scholar
• Humphrey LJ, Estes NC, Morse PA, et al: Serum antibody inpatients with mammary disease. Cancer 34:1516–1520, 1974
   PubMed Web of Science ®Google Scholar
• Gunvén P, Klein G, Clifford P, et al: Epstein-Barr virus- associated membrane-reactive antibodies during long term survival after Burkitt's lymphoma. Proc Natl Acad Sci USA 71:1422–1426, 1974
   PubMedGoogle Scholar
• Mathé G, Weiner R, Pouillart P, et al: BCG in cancer immunotherapy: Experimental and clinical trials of its use in treatment of leukemia minimal and/or residual disease. Natl Cancer Inst Monogr 39:165–175, 1973
   PubMedGoogle Scholar
• Powles R: Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells. Cancer 34:1558–1562, 1974
   PubMed Web of Science ®Google Scholar
• Morton DL, Eilber FR, Holmes EC, et al: BCG immunotherapy of malignant melanoma: Summary of a seven-year experience. In Crispen RG (Editor): Neoplasm Immunity: BCG Vaccination. Evanston, Schori Press, 1974, pp 97–110
   Google Scholar
• Gutterman JU, Mavligit GM, Reed RC, et al: Chemoimmunotherapy for regional and disseminated malignant melanoma. In: Cancer Chemotherapy. Chicago, Year Book Medical Publishers, Inc, 1975, pp 455–482
   Google Scholar
• Israel L: Preliminary results of nonspecific immunotherapy for lung cancer. Cancer Chemother Rep, Suppl 4, 4:283–286, 1973
   Google Scholar
• Sinkovics JG, Harris JE: Immunology and immunotherapy of human tumors. In Harris, Sinkovics8
   Google Scholar
• Thomas ED, Storb R, Clift RA, et al: Bone marrow transplantation. N Engl J Med 292:832–843, 895–902, 1975
   PubMed Web of Science ®Google Scholar
• Marcolongo R, Di Paolo N: Fetal thymic transplant in patients with Hodgkin's disease. Blood 41:625–633, May 1973
   PubMed Web of Science ®Google Scholar
• Incefy GS, L'Esperance P, Good RA: In vitro differentiation of human marrow cells into T lymphocytes by thymic extracts using the rosette technique. Clin Exp Immunol 19:475–483, 1975
   PubMed Web of Science ®Google Scholar
• Spider LE, Levin AS, Fudenberg HH: Human lymphocyte transfer factor. In Busch H (Editor): Methods in Cancer Research. New York, Academic Press, Inc, 1973, pp 59–106
   Google Scholar
• Neidhart JA, LoBuglio AF: Transfer factor therapy of malignancy. Seminars in Oncology 1:379–385, 1974
   PubMedGoogle Scholar
• Pilch YH, deKernion JB: Immunotherapy of cancer with “immune” RNA: Current status. Seminars in Oncology 1:387–395, 1974
   Google Scholar
• Sinkovics JG, Thota H, Loh KK, et al: Prospectives for immunotherapy for human sarcomas. In: Cancer Chemotherapy,29 pp 417–443
   Google Scholar